Advertisement

Topics

Bonti Announces Presentation of EB-001 Clinical Study Results at American Society for ...

03:06 EDT 13 Sep 2017 | BioMedReports - Blog
Poster Highlighting Novel Neurotoxin’s Phase 2a Glabellar Lines Study Data Featured in October in Chicago, IL

Read more...

Original Article: Bonti Announces Presentation of EB-001 Clinical Study Results at American Society for ...

NEXT ARTICLE

More From BioPortfolio on "Bonti Announces Presentation of EB-001 Clinical Study Results at American Society for ..."

Quick Search
Advertisement